INVEGA TRINZA Drug Patent Profile
✉ Email this page to a colleague
When do Invega Trinza patents expire, and what generic alternatives are available?
Invega Trinza is a drug marketed by Janssen Pharms and is included in one NDA. There is one patent protecting this drug and three Paragraph IV challenges.
This drug has fifty-four patent family members in twenty-six countries.
The generic ingredient in INVEGA TRINZA is paliperidone palmitate. There are thirty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the paliperidone palmitate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Invega Trinza
A generic version of INVEGA TRINZA was approved as paliperidone palmitate by TEVA PHARMS USA on July 6th, 2021.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for INVEGA TRINZA?
- What are the global sales for INVEGA TRINZA?
- What is Average Wholesale Price for INVEGA TRINZA?
Summary for INVEGA TRINZA
International Patents: | 54 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Patent Applications: | 139 |
Drug Prices: | Drug price information for INVEGA TRINZA |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for INVEGA TRINZA |
What excipients (inactive ingredients) are in INVEGA TRINZA? | INVEGA TRINZA excipients list |
DailyMed Link: | INVEGA TRINZA at DailyMed |


Pharmacology for INVEGA TRINZA
Drug Class | Atypical Antipsychotic |
Paragraph IV (Patent) Challenges for INVEGA TRINZA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
INVEGA TRINZA | Extended-release Injectable Suspension | paliperidone palmitate | 273 mg/0.875 mL and 410 mg/1.315 mL | 207946 | 1 | 2021-07-14 |
INVEGA TRINZA | Extended-release Injectable Suspension | paliperidone palmitate | 819 mg/2.625 mL | 207946 | 1 | 2021-04-30 |
INVEGA TRINZA | Extended-release Injectable Suspension | paliperidone palmitate | 546 mg/1.75 mL | 207946 | 1 | 2020-06-24 |
US Patents and Regulatory Information for INVEGA TRINZA
INVEGA TRINZA is protected by two US patents.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-001 | May 18, 2015 | RX | Yes | Yes | ⤷ Free Trial | ⤷ Free Trial | ⤷ Free Trial | ||||
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-004 | May 18, 2015 | RX | Yes | Yes | ⤷ Free Trial | ⤷ Free Trial | ⤷ Free Trial | ||||
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-002 | May 18, 2015 | RX | Yes | Yes | ⤷ Free Trial | ⤷ Free Trial | ⤷ Free Trial | ||||
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-003 | May 18, 2015 | RX | Yes | Yes | ⤷ Free Trial | ⤷ Free Trial | ⤷ Free Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for INVEGA TRINZA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-001 | May 18, 2015 | ⤷ Free Trial | ⤷ Free Trial |
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-004 | May 18, 2015 | ⤷ Free Trial | ⤷ Free Trial |
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-003 | May 18, 2015 | ⤷ Free Trial | ⤷ Free Trial |
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-002 | May 18, 2015 | ⤷ Free Trial | ⤷ Free Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for INVEGA TRINZA
When does loss-of-exclusivity occur for INVEGA TRINZA?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Australia
Patent: 16244801
Estimated Expiration: ⤷ Free Trial
Patent: 20239611
Estimated Expiration: ⤷ Free Trial
Patent: 22221405
Estimated Expiration: ⤷ Free Trial
Patent: 24227790
Estimated Expiration: ⤷ Free Trial
Brazil
Patent: 2017021383
Estimated Expiration: ⤷ Free Trial
Canada
Patent: 25908
Estimated Expiration: ⤷ Free Trial
Patent: 88401
Estimated Expiration: ⤷ Free Trial
Croatia
Patent: 0201027
Estimated Expiration: ⤷ Free Trial
Patent: 0240022
Estimated Expiration: ⤷ Free Trial
Cyprus
Patent: 23203
Estimated Expiration: ⤷ Free Trial
Denmark
Patent: 80416
Estimated Expiration: ⤷ Free Trial
Patent: 44326
Estimated Expiration: ⤷ Free Trial
Eurasian Patent Organization
Patent: 7185
Estimated Expiration: ⤷ Free Trial
Patent: 1792209
Estimated Expiration: ⤷ Free Trial
European Patent Office
Patent: 80416
Estimated Expiration: ⤷ Free Trial
Patent: 44326
Estimated Expiration: ⤷ Free Trial
Patent: 49323
Estimated Expiration: ⤷ Free Trial
Finland
Patent: 44326
Estimated Expiration: ⤷ Free Trial
Hong Kong
Patent: 49047
Estimated Expiration: ⤷ Free Trial
Hungary
Patent: 49485
Estimated Expiration: ⤷ Free Trial
Patent: 65435
Estimated Expiration: ⤷ Free Trial
Israel
Patent: 4669
Estimated Expiration: ⤷ Free Trial
Patent: 9340
Estimated Expiration: ⤷ Free Trial
Japan
Patent: 28221
Estimated Expiration: ⤷ Free Trial
Patent: 28503
Estimated Expiration: ⤷ Free Trial
Patent: 22277
Estimated Expiration: ⤷ Free Trial
Patent: 18510894
Estimated Expiration: ⤷ Free Trial
Patent: 20090498
Estimated Expiration: ⤷ Free Trial
Patent: 21130680
Estimated Expiration: ⤷ Free Trial
Lithuania
Patent: 80416
Estimated Expiration: ⤷ Free Trial
Patent: 44326
Estimated Expiration: ⤷ Free Trial
Moldova, Republic of
Patent: 80416
Estimated Expiration: ⤷ Free Trial
Patent: 44326
Estimated Expiration: ⤷ Free Trial
Morocco
Patent: 917
Patent: Schéma de traitement en cas de doses oubliées pour des esters de palipéridone injectables à action prolongée
Estimated Expiration: ⤷ Free Trial
Patent: 511
Patent: SCHÉMA DE TRAITEMENT EN CAS DE DOSES OUBLIÉES POUR DES ESTERS DE PALIPÉRIDONE INJECTABLES À ACTION PROLONGÉE
Estimated Expiration: ⤷ Free Trial
New Zealand
Patent: 5952
Patent: Dosing regimen for missed doses for long-acting injectable paliperidone esters
Estimated Expiration: ⤷ Free Trial
Patent: 8246
Patent: Dosing regimen for missed doses for long-acting injectable paliperidone esters
Estimated Expiration: ⤷ Free Trial
Poland
Patent: 80416
Estimated Expiration: ⤷ Free Trial
Patent: 44326
Estimated Expiration: ⤷ Free Trial
Portugal
Patent: 80416
Estimated Expiration: ⤷ Free Trial
Patent: 44326
Estimated Expiration: ⤷ Free Trial
Serbia
Patent: 510
Patent: DOZNI REŽIM ZA PROPUŠTENE DOZE INJEKTIBILNIH ESTARA PALIPERIDONA SA PRODUŽENIM DELOVANJEM (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷ Free Trial
Patent: 024
Patent: DOZNI REŽIM ZA PROPUŠTENE DOZE INJEKTIBILNIH ESTARA PALIPERIDONA SA PRODUŽENIM DELOVANJEM (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷ Free Trial
Slovenia
Patent: 80416
Estimated Expiration: ⤷ Free Trial
Patent: 44326
Estimated Expiration: ⤷ Free Trial
South Korea
Patent: 2606678
Estimated Expiration: ⤷ Free Trial
Patent: 170134583
Estimated Expiration: ⤷ Free Trial
Patent: 230162162
Estimated Expiration: ⤷ Free Trial
Spain
Patent: 02299
Estimated Expiration: ⤷ Free Trial
Patent: 67585
Estimated Expiration: ⤷ Free Trial
Taiwan
Patent: 94825
Estimated Expiration: ⤷ Free Trial
Patent: 1642863
Patent: Dosing regimen for missed doses for long-acting injectable Paliperidone esters
Estimated Expiration: ⤷ Free Trial
Ukraine
Patent: 8732
Patent: СХЕМА ВВЕДЕННЯ ПРОПУЩЕНИХ ДОЗ ЕСТЕРІВ ПАЛІПЕРИДОНУ ТРИВАЛОЇ ДІЇ ДЛЯ ІН'ЄКЦІЙНОГО ЗАСТОСУВАННЯ (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷ Free Trial
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering INVEGA TRINZA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Portugal | 4025187 | ⤷ Free Trial | |
San Marino | T202400077 | ⤷ Free Trial | |
Spain | 2973583 | ⤷ Free Trial | |
Denmark | 3280416 | ⤷ Free Trial | |
Indonesia | 16927 | ⤷ Free Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for INVEGA TRINZA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0904081 | 416 | Finland | ⤷ Free Trial | |
0904081 | 1190023-0 | Sweden | ⤷ Free Trial | PRODUCT NAME: PALIPERIDONPALMITAT; REG. NO/DATE: EU/1/11/672/001-006 20110304 |
0904081 | CA 2011 00020 | Denmark | ⤷ Free Trial | |
0368388 | SPC/GB07/065 | United Kingdom | ⤷ Free Trial | PRODUCT NAME: PALIPERIDONE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/07/395/001 20070625; UK EU/1/07/395/002 20070625; UK EU/1/07/395/003 20070625; UK EU/1/07/395/004 20070625; UK EU/1/07/395/005 20070625; UK EU/1/07/395/006 20070625; UK EU/1/07/395/007 20070625; UK EU/1/07/395/008 20070625; UK EU/1/07/395/009 20070625; UK EU/1/07/395/010 20070625; UK EU/1/07/395/011 20070625; UK EU/1/07/395/012 20070625; UK EU/1/07/395/013 20070625; UK EU/1/07/395/014 20070625; UK EU/1/07/395/015 20070625; UK EU/1/07/395/016 20070625; UK EU/1/07/395/017 20070625; UK EU/1/07/395/018 20070625; UK EU/1/07/395/019 20070625; UK EU/1/07/395/020 20070625; UK EU/1/07/395/021 |
0904081 | PA2011008,C0904081 | Lithuania | ⤷ Free Trial | PRODUCT NAME: PALIPERIDONI PALMITAS; REGISTRATION NO/DATE: EU/1/11/672/001 - EU/1/11/672/006 20110304 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory for INVEGA TRINZA
More… ↓